Sinking Burning Rock faces de-listing. But could privatization bid come first?
The cancer-screening products maker is in danger of being forcibly delisted due to its sinking stock price, as income from its former top revenue source tumbles amid an industry crackdown…
Fresh test for cancer-screening firm Genetron after Nasdaq exit
The onetime star of the U.S. stock market is being privatized with the help of new investors as it adapts to tough challenges in China’s cancer-testing industry Key Takeaways: Genetron…
FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business
The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
New Horizon’s Sales Surge as China Promotes Early Cancer Detection
Company’s first-mover advantage in at-home colorectal screening and China’s focus on early detection have turbocharged sales, though valuation remains frothy Key takeaways: New Horizon’s first-half revenues jumped more than fourfold,…
